STAT

FEBRUARY 9, 2024

In January 2023, minutes after Damar Hamlin  collapsed  on the field following a tackle, my cellphone was humming with a steady stream of messages from friends, family, and acquaintances who had been watching the game. How could this happen, they wanted to know. Could a single, seemingly routine collision between two very-large men really cause one of their hearts to abruptly stop beating?

353

353

ALiEM - Pharm Pearls

FEBRUARY 9, 2024

How do we best use high-sensitivity cardiac troponin (hs-cTn) to risk stratify patients with symptoms concerning for an acute myocardial infarction (AMI)? The 2022 American College of Cardiology (ACC) pathway provides timely guidance [1]. We help you translate this to your clinical practice, by illustrating with a case. Time to know your hs-cTn better.

Hospitals 276

Hospitals Diabetes 276

STAT

FEBRUARY 9, 2024

WASHINGTON — A bipartisan group of senators is starting work on legislation to reform how Medicare pays physicians, they will announce Friday. Senate Minority Whip John Thune (R-S.D.) and Sens. Marsha Blackburn (R-Tenn.), John Barrasso (R-Wyo.), Debbie Stabenow (D-Mich.), Mark Warner (D-Va.), and Catherine Cortez Masto (D-Nev.) announced their intent to develop long-term fixes to issues with Medicare’s physician payment structure and to update the Medicare Access and CHIP Reauthori

328

328

PharmaVoice

FEBRUARY 9, 2024

After a big 2023, Yoshi Shitaka said the company is banking on gene therapies, KRAS degraders and more to keep the momentum.

265

265

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

FEBRUARY 9, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Our podcast this week centers exclusively on a tantalizing subject: Artificial intelligence in biotech. Give it a listen. Also, Moderna’s RSV vaccine efficacy seems lackluster compared to competitors, and the Bernie Sanders drug pricing song-and-dance did not seem to faze pharma CEOs.

Vaccines 291

Vaccines Drug Pricing Drug Development 291

pharmaphorum

FEBRUARY 9, 2024

Learn how implementing a SMART approach in stem cell manufacturing can lead to improved efficiency and cost reduction for the production of mesenchymal stem cells (MSCs) used in the treatment of osteoarthritic and autoimmune conditions.

118

118

European Pharmaceutical Review

FEBRUARY 9, 2024

BioNTech SE and Autolus Therapeutics have agreed to collaborate to advance autologous CAR-T cell therapies. Under the terms of the agreement, BioNTech will pay $50 million to Autolus, granting the immunotherapy company rights including the option to access Autolus’ commercial and clinical site network, manufacturing capacities in the UK and commercial supply infrastructure.

111

111

STAT

FEBRUARY 9, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

246

246

pharmaphorum

FEBRUARY 9, 2024

The combination of drugs for hypertension and software to personalise dosing to an individual patient has been shown to deliver improved blood pressure control and adherence to therapy in a pilot study.

117

117

Pharmaceutical Commerce

FEBRUARY 9, 2024

Researchers explore the proportion of approved drugs in the Canadian marketplace that utilize manufacturer-sponsored patient support programs, along with the types of medications that are more likely to do so.

105

105

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

FEBRUARY 9, 2024

Measuring the success or failure of UK MedTech companies is complex and multi-faceted, but it is undoubtedly influenced by two significant factors. Read on to learn more.

117

117

FDA Law Blog: Biosimilars

FEBRUARY 9, 2024

By Adrienne R. Lenz, Principal Medical Device Regulation Expert & Lisa M. Baumhardt, Senior Medical Device Regulation Expert — As an end of the year gift, FDA finalized its guidance document, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations , in late December. We previously blogged on the draft guidance ( here ) and on FDA’s broader framework for Digital Health Technologies (DHT) ( here and here ).

Documentation 104

Documentation 104

Pharma Times

FEBRUARY 9, 2024

The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy

138

138

The Pharmacist

FEBRUARY 9, 2024

Pharmacist access to patient records is ‘more urgent than ever’, Royal Pharmaceutical Society (RPS) director for Scotland Laura Wilson will tell new health secretary Neil Gray. This comes as Mr Gray replaces former cabinet secretary for NHS recovery, health and social care Michael Matheson, who resigned yesterday following an investigation into data roaming charges he […] The post Call for patient records access as new Scottish ministers appointed appeared first on The Pharmacist.

101

101

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

FEBRUARY 9, 2024

A paper published in the European Journal of Pharmaceutics and Biopharmaceutics has detailed the successful development of ebselen as an inhalable dry powder formulation. This is one of the most effective ways of treating respiratory infections, the authors asserted. The approach, which uses a spray-drying technique, will allow inhalable antimicrobials as dry powder formulations to be developed” The approach, which uses a spray-drying technique, will allow inhalable antimicrobials as dry p

Dosage 97

Dosage 97

pharmaphorum

FEBRUARY 9, 2024

Discover insights from Trevor Martin, the co-founder and CEO of Mammoth Biosciences, in an exclusive interview from JP Morgan for 2024. Gain valuable knowledge about Mammoth Biosciences and the future of biotech innovation.

106

106

Pharmaceutical Commerce

FEBRUARY 9, 2024

A dive into the intricacies of how to ensure a long-running event stays fresh and relevant to the needs of the pharmaceutical industry.

111

111

Pharmaceutical Technology

FEBRUARY 9, 2024

Pharma CEOs defended their high prescription drug costs, stating that the current prices are necessary for continued innovation.

Drug Pricing 113

Drug Pricing 113

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

FEBRUARY 9, 2024

Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to manufacture and market Dexamethasone Tablets USP, 1 mg (USRLD: Dexamethasone Tablets). Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders.

Immunization 101

Immunization Immunity 101

Pharmaceutical Technology

FEBRUARY 9, 2024

AstraZeneca has reported a significant 81% rise in profit after tax, reaching $5.96bn for FY 2023 from $3.29bn in the previous year.

105

105

Pharma Times

FEBRUARY 9, 2024

OART is increasingly emerging to assess and adapt treatment for cancer patients

119

119

Pharmaceutical Technology

FEBRUARY 9, 2024

Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.

97

97

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Channels

FEBRUARY 9, 2024

Today’s guest post comes from Nasir Ali, Chief Product Officer at CareMetx. Nasir shares findings from CareMetx’s new 2024 Patient Services Report research study: Revealing Manufacturer Priorities: Patients Naturally Take Center Stage. As he explains, manufacturers want hub partners that can take a holistic approach and address each patient’s individual needs.

78

78

Pharmaceutical Technology

FEBRUARY 9, 2024

Nippon will pay $10m upfront and up to $275m in milestone-based payments for the developmental and commercial rights to Vicore’s C21 in Japan.

90

90

The Pharmacist

FEBRUARY 9, 2024

A proposal to subsidise prescriptions for e-cigarettes in an HRT certificate-style scheme has been mooted during a parliamentary inquiry. Professor Javed Khan, author of the Khan Review, ‘Making Smoking Obsolete’, gave evidence to the Health and Social Care Select Committee (HSCC), as part of an inquiry into preventing ill-health, on Monday. Professor Khan welcomed the […] The post Subsidising vapes on prescription ‘should be considered’, MPs told appeared first on The Pharmacist.

81

81

EMCrit Project

FEBRUARY 9, 2024

The acute crit care med rec EMCrit Project by Scott Weingart, MD FCCM.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

FEBRUARY 9, 2024

Shortly after Kyverna priced one of the sector’s largest IPOs in recent years, Maag spoke with BioPharma Dive about what it takes to go public now.

75

75

The Pharmacist

FEBRUARY 9, 2024

A report considering how HIV prevention drug Pre-Exposure Prophylaxis (PrEP) could be made available through community pharmacies will be published within days, the pharmacy minister has confirmed. In a parliamentary debate to mark national HIV testing week in the house of commons yesterday, Labour MP for Hammersmith Andrew Slaughter highlighted issues around access to PrEP. […] The post Report considering pharmacy access to PrEP to come ‘next week’ appeared first on The Pharmacist.

Community Pharmacies 77

Community Pharmacies 77

Pharmafile

FEBRUARY 9, 2024

BioNTech and Autolus Therapeutics have announced that they have entered a strategic collaboration intended to further both companies’ autologous CAR T programmes towards commercialisation following regulatory authorisations. The companies have also entered into a license and option agreement and a securities purchase agreement. BioNTech has agreed to purchase $200m of Autolos’ American Depositary Shares in […] The post BioNTech and Autolus announce CAR T-cell therapy collaboration appeared

69

69

PharmaTech

FEBRUARY 9, 2024

The three non-commercial developers of ATMPs will benefit from enhanced support from the agency.

96

96

BioPharma Dive

FEBRUARY 9, 2024

New results have convinced Takeda to “rapidly” pursue a late-stage program for its drug TAK-861 in one type of narcolepsy, while in another the company opted not to continue.

67

67